Targeting PARP-1 and DNA Damage Response Defects in Colorectal Cancer Chemotherapy with Established and Novel PARP Inhibitors.
DNA damage response
PARP-1
chemotherapy
colorectal cancer
synthetic lethality
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
10 Oct 2024
10 Oct 2024
Historique:
received:
28
08
2024
revised:
28
09
2024
accepted:
07
10
2024
medline:
26
10
2024
pubmed:
26
10
2024
entrez:
26
10
2024
Statut:
epublish
Résumé
The DNA repair protein PARP-1 emerged as a valuable target in the treatment of tumor entities with deficiencies of
Identifiants
pubmed: 39456536
pii: cancers16203441
doi: 10.3390/cancers16203441
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Deutsche Forschungsgemeinschaft
ID : INST 248/331-1 FUGG
Organisme : Deutsche Forschungsgemeinschaft
ID : INST 292/161-1 FUGG
Organisme : Wilhelm Sander Stiftung
ID : 2016.039.2